These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7732057

  • 41. A search for new 5-HT1A/5-HT2A receptor ligands. In vitro and in vivo studies of 1-[omega-(4-aryl-1-piperazinyl)alkyl]indolin-2(1H)-ones.
    Mokrosz MJ, Duszyńska B, Misztal S, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Dziedzicka-Wasylewska M.
    Arch Pharm (Weinheim); 1998 Oct; 331(10):325-30. PubMed ID: 9844580
    [Abstract] [Full Text] [Related]

  • 42. N-[omega-[4-(2-methoxyphenyl)-1-piperazinyl]alkyl]-2-quinolinamines as high-affinity fluorescent 5-HT1A receptor ligands.
    Lacivita E, Leopoldo M.
    J Med Chem; 2008 Mar 13; 51(5):1492-5. PubMed ID: 18269229
    [Abstract] [Full Text] [Related]

  • 43. Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site.
    Mokrosz JL, Bojarski AJ, Maćkowiak M, Bielecka Z, Boksa J.
    Pharmazie; 1994 May 13; 49(5):328-33. PubMed ID: 8016178
    [Abstract] [Full Text] [Related]

  • 44. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F, Colabufo NA, Giudice G, Perrone R, Tortorella V, Govoni S, Lucchi L.
    J Med Chem; 1996 Jan 05; 39(1):176-82. PubMed ID: 8568804
    [Abstract] [Full Text] [Related]

  • 45. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 46. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F, Severino B, De Angelis F, Perissutti E, Frecentese F, Massarelli P, Bruni G, Collavoli E, Santagada V, Caliendo G.
    Arch Pharm (Weinheim); 2008 Jan 15; 341(1):20-7. PubMed ID: 18072244
    [Abstract] [Full Text] [Related]

  • 47. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A, Esteban S, Sastre-Coll A, Moranta D, Asensio VJ, García-Sevilla JA.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):234-42. PubMed ID: 16061219
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Structure-activity relationship studies of CNS agents. Part 4: 2-[3-(4-aryl-1-piperazinyl)propyl]-1,2,3,4-tetrahydro-beta-carbolin+ ++ -1-one derivatives as potential central anti-serotonin agents.
    Boksa J, Misztal S, Chojnacka-Wójcik E, Gastoł-Lewińska L, Gródecka A, Mokrosz JL.
    Pharmazie; 1992 Apr 22; 47(4):254-7. PubMed ID: 1518881
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T.
    Eur J Pharmacol; 2005 Jul 11; 517(3):165-73. PubMed ID: 15985260
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G.
    J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Synthesis of potent and selective serotonin 5-HT1B receptor ligands.
    Huang Y, Bae SA, Roth BL, Laruelle M.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4786-9. PubMed ID: 16143528
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
    Khorana N, Smith C, Herrick-Davis K, Purohit A, Teitler M, Grella B, Dukat M, Glennon RA.
    J Med Chem; 2003 Aug 28; 46(18):3930-7. PubMed ID: 12930153
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.